Phase 2 Metastatic Colorectal Cancer Clinical Trials
13 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–13 of 13 trials
Recruiting
Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Metastatic Breast CarcinomaMetastatic Ovarian CancerMetastatic Pancreatic Cancer+2 more
National Cancer Institute (NCI)332 enrolled1 locationNCT01174121
Recruiting
Phase 2
Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Sun Yat-sen University198 enrolled3 locationsNCT05959356
Recruiting
Phase 1Phase 2
A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
Metastatic Colorectal CancerProstate Cancer MetastaticProstate Cancer Locally Advanced
Curacell Holding AB12 enrolled1 locationNCT07255664
Recruiting
Phase 2
Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1)
Metastatic Colorectal CancerFirst-line TreatmentOrganoids+3 more
St. Olavs Hospital148 enrolled1 locationNCT06907342
Recruiting
Phase 1Phase 2
Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Liu Huang42 enrolled1 locationNCT06980532
Recruiting
Phase 2
Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
Metastatic Colorectal Cancer
Centre Hospitalier Universitaire de Besancon174 enrolled10 locationsNCT06425133
Recruiting
Phase 2
Combination Therapy for BRAF-V600E Metastatic CRCm
Metastatic Colorectal Cancer
Vall d'Hebron Institute of Oncology94 enrolled1 locationNCT06411600
Recruiting
Phase 2
A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
Metastatic Colorectal Cancer
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.130 enrolled1 locationNCT06493760
Recruiting
Phase 2
FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
UMC Utrecht40 enrolled1 locationNCT06563986
Recruiting
Phase 2
ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer
Metastatic Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences68 enrolled1 locationNCT06543836
Recruiting
Phase 2
Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC
Metastatic Colorectal CancerDrug Therapy
First Affiliated Hospital of Wenzhou Medical University200 enrolled1 locationNCT06485713
Recruiting
Phase 2
Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Dominik Paul Modest153 enrolled1 locationNCT05007132
Recruiting
Phase 2
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Oslo University Hospital40 enrolled1 locationNCT05725200